Filing Details
- Accession Number:
- 0001225208-24-005005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-08 17:10:58
- Reporting Period:
- 2024-04-08
- Accepted Time:
- 2024-04-08 17:10:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1710625 | M Jean-Luc Lemercier | One Edwards Way Irvine CA 92614 | Cvp, Emeacla | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-08 | 14,400 | $36.75 | 188,249 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-08 | 107 | $92.65 | 188,142 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-04-08 | 14,293 | $92.32 | 173,849 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2024-04-08 | 14,400 | $0.00 | 14,400 | $36.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,400 | 2018-05-11 | 2024-05-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023.
- This transaction was executed in multiple trades at prices ranging from $91.65 to $92.61. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.